Infection Control Find the newest stories covering infection and disease control in hospitals, care homes, and the general population. This section contains information on testing, monitoring, treatment options, vaccine development and distribution, as well as new policy decisions and best practices. Also included are announcements of educational and awareness campaigns. Follow new advances in infection control and prevention with releases about new study results and updated statistical data and analysis.

Latest

Feb 01, 2017, 16:19 ET Norovirus Outbreaks: Squaremouth Explains Travel Insurance Coverage for Cruisers

Norovirus outbreaks are spreading throughout the United States, not only affecting travelers while on a cruise, but preventing some from taking a...


Feb 01, 2017, 14:41 ET Educar a los adolescentes en materia sexual, crucial para evitar embarazos no deseados: Janssen

Janssen México, compañía farmacéutica de Johnson & Johnson, reunió a especialistas en sexualidad y actores clave del sector salud para hablar...


Feb 01, 2017, 08:00 ET Emmaus Life Sciences, Inc. Receives Notice of Allowance for U.S. Patent for use of L-glutamine in Treatment of Diverticulosis

Emmaus announced today the allowance by the US Patent & Trade Office of patent application number 13/694,592 covering the use of its lead...


Feb 01, 2017, 07:30 ET MRIGlobal Wins $13.7M NIH/NIAID Quality Assessment Contract For Mycobacterium Tuberculosis

MRIGlobal has been awarded a contract (Contract No. HHSN272201700001C) from the National Institute of Allergy and Infectious Diseases (NIAID), a...


Jan 30, 2017, 15:16 ET NYU Lutheran's Unique Insight into "Global Medicine"

Brooklyn is one of the country's most populous "melting pots." The borough is home to a large number of people from Asian and African countries, as...


Jan 26, 2017, 18:44 ET Global Influenza Diagnostics Market Research Report - Industry Analysis, Size, Share, Growth, Trends And Forecast

The report on global influenza diagnostics market evaluates the growth trends of the industry through historical study and estimates future...


Jan 26, 2017, 16:05 ET QIAGEN's QuantiFERON-TB Test Wins Tender for Testing of Republic of Korea Armed Forces Recruits

QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced that QuantiFERON®-TB Gold (QFT), the modern standard for accuracy in...


Jan 26, 2017, 08:19 ET Sequencing Platform Providers Aim to Develop Tests for Infectious Diseases to Expand Market Opportunity

Newer capabilities enabled by Next-Generation Sequencing (NGS) are expanding opportunities for the platform in clinical applications. While the...


Jan 25, 2017, 07:44 ET Vioguard Secures $5MM Series A Financing Round Led by Imagen Capital Partners

Vioguard Inc., an industry leader in UV-C technology solutions, today announced that it has raised a $5 million Series A round of financing from...


Jan 25, 2017, 07:00 ET Researchers Announce Plans for Study of Candidate Blood Test to Detect Chronic Traumatic Encephalopathy (CTE) in Former NFL Players

Researchers with Exosome Sciences, Inc., a diagnostic subsidiary of Aethlon Medical, Inc. (Nasdaq: AEMD), a therapeutic technology company, today...


Jan 24, 2017, 09:00 ET PDI Welcomes Industry-Leading Experts to Further the Advancement of its leading Infection Prevention Technology

PDI, a leader in infection prevention products and solutions, announces an exclusive relationship with two of the world's leading experts in...


Jan 24, 2017, 08:00 ET Aptuit Announces Drug Discovery Collaboration with Massachusetts General Hospital (MGH) to Identify Novel Treatments for Gram-Negative Infections

Aptuit, LLC today announced the start of a collaboration with the Molecular Surgical Laboratory of Massachusetts General Hospital (MGH), directed...


Jan 24, 2017, 02:00 ET Aptuit annonce une collaboration portant sur la découverte de médicaments avec le Massachusetts General Hospital (MGH) pour identifier de nouveaux traitements pour les infections à bacille gram négatif

Aptuit, LLC a annoncé aujourd'hui le début d'une collaboration avec le laboratoire de chirurgie moléculaire du Massachusetts General Hospital...


Jan 24, 2017, 02:00 ET Aptuit verkündet gemeinsame Arzneimittelforschung mit Massachusetts General Hospital (MGH) zur Identifizierung neuartiger Therapieansätze für gramnegative Infektionen

Aptuit, LLC, hat heute den Beginn eines Gemeinschaftsprojekts mit dem Molecular Surgical Laboratory des Massachusetts General Hospital (MGH)...


Jan 24, 2017, 02:00 ET Aptuit colaborará con el Hospital General de Massachusetts en descubrimiento de fármacos

- Aptuit anuncia una colaboración con el Hospital General de Massachusetts en descubrimiento de fármacos para identificar nuevos tratamientos...


Jan 23, 2017, 07:00 ET Oxitec and GBIT Announce Launch of Friendly™ Aedes Project in India

Gangabishan Bhikulal Investment and Trading Limited (GBIT) and Oxitec announced today the launch of the Friendly™ Aedes project in Dawalwadi,...


Jan 20, 2017, 13:37 ET South African Study Provides Compelling New Evidence on Role of Person-to Person Transmission in Drug-Resistant TB Epidemics

A study published today in The New England Journal of Medicine provides compelling evidence that extensively drug-resistant tuberculosis (XDR TB)...


Jan 20, 2017, 11:00 ET Huit personnes arrêtées en Guinée pour la vente illégale de médicaments antipaludiques

Le Bureau de l'inspecteur général de l'USAID agit pour arrêter le vol de marchandises financées par les États-Unis Cette semaine, une...


Jan 19, 2017, 16:25 ET 8 Arrested in Guinea for Illicit Sale of Antimalarial Drugs

This week, an investigation by the U.S. Agency for International Development (USAID) Office of Inspector General (OIG) led local authorities in...


Jan 19, 2017, 13:29 ET Ceva finalise un accord en vue du rachat du portefeuille d'anti-inflammatoires non-stéroïdiens et de vaccins Merial destinés aux porcins et aux bovins de Boehringer Ingelheim

Ceva Santé Animale a finalisé ce jour l'acquisition d'un portefeuille diversifié de produits, comprenant des vaccins destinés aux porcins et aux...


Jan 19, 2017, 12:43 ET Ceva schließt Abkommen zum Erwerb des Portfolios von Impfstoffen für Schweine und Kühe von Merial sowie nichtsteroidalen entzündungshemmenden Medikamenten von Boehringer Ingelheim ab

Nach der Akquisition von Merial Animal Health schloss Ceva Santé Animale heute die Akquisition eines vielfältigen Produktportfolios ab, zu dem...


Jan 19, 2017, 11:35 ET Ceva adquiere la cartera de vacunas de ganado porcino y vacuno de Merial

- Ceva cierra el acuerdo para adquirir la cartera de vacunas de ganado porcino y vacuno de Merial y antiinflamatorios no esteroideos de Boehringer...


Jan 19, 2017, 08:00 ET Symbiomix Therapeutics Submits New Drug Application to US FDA for Solosec™ for the Treatment of BV

Symbiomix, a biopharmaceutical company bringing innovative medicines to market for prevalent gynecological infections, today announced submission...


Jan 18, 2017, 17:53 ET Hepatitis C-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

DelveInsight's Report, "Hepatitis C-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016", provides comprehensive insights about...


Jan 18, 2017, 08:00 ET Quest Diagnostics Launches Nation's First Hepatitis B Virus Quantitative Test to Help Assess Response to Antiviral Therapy

Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced the launch of a new test service...